Albumin Market Analysis: $7.81 Billion Market Size In 2026 And Future Growth Prospects
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Albumin Market Poised To Hit $10.62 Billion By 2030 With A 8% CAGR
The albumin market has witnessed significant growth in recent years. It is projected to expand from $7.16 billion in 2025 to $7.81 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.1%. This historical expansion was primarily driven by factors such as the restricted availability of plasma-derived albumin, a rising incidence of liver diseases and burns, its expanded application in diagnostic kits, increasing biopharmaceutical research and development activities, and its early integration into laboratory and research applications.
The albumin market is projected to experience substantial expansion over the upcoming years, with its valuation anticipated to reach $10.62 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This projected growth during the forecast period is primarily driven by improvements in recombinant albumin technology, the increasing need for personalized medicine, the broader integration of albumin into drug delivery systems, a surge in biopharmaceutical production, and escalating investments in both therapeutic and cosmetic uses. Key trends observed within this period encompass an escalating demand for human serum albumin in therapeutic contexts, the widening application of albumin in drug formulations and vaccines, the broadening scope of recombinant albumin in biopharmaceutical applications, increased incorporation of albumin in cell culture and diagnostic kits, and a heightened emphasis on albumin-centric research and personalized medical approaches.
Get A Free Sample Report With In-Depth Market Insights:
Albumin Market Demand Drivers Opening New Revenue Streams
The increasing occurrence of diabetes is anticipated to drive the expansion of the albumin market in the future. Diabetes, a persistent metabolic condition marked by high blood sugar levels, can progressively lead to kidney issues like diabetic nephropathy. A primary contributor to the growing prevalence of diabetes is the increase in obesity rates, as significant epidemiological data illustrates a robust link between elevated body mass index levels and a considerably heightened risk of diabetes. Albumin assists in patient care by aiding the monitoring of kidney function and directing therapeutic interventions for individuals with diabetes. For example, data from April 2025, supplied by the International Diabetes Federation (IDF), a Belgium-based non-profit organization, indicates that diabetes impacted an estimated 589 million adults and 9.5 million people with type 1 diabetes in 2024, including 1.9 million children and adolescents, with the total number of people living with the condition forecast to reach 853 million by 2050. Consequently, the escalating incidence of diabetes is fueling the expansion of the albumin market.
Albumin Market Segment Analysis And Revenue Potential
The albumin market covered in this report is segmented –
1) By Type: Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin
2) By Application: Therapeutics, Drug Formulation And Vaccines, Component Of Media, Other Applications
3) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Research Institutes
Subsegments:
1) By Human Serum Albumin: Plasma-Derived Human Serum Albumin, Recombinant Human Serum Albumin, Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns), Human Serum Albumin For Drug Delivery And Research Applications
2) By Bovine Serum Albumin: Bovine Serum Albumin For Laboratory Use (In Cell Culture), Bovine Serum Albumin For Diagnostic Kits, Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals
3) By Recombinant Albumin: Recombinant Human Albumin For Therapeutic Applications, Recombinant Albumin For Biopharmaceutical Formulation, Recombinant Albumin For Cosmetic And Personal Care Applications, Recombinant Albumin For Research And Diagnostic Applications
Albumin Market Trends Powering Strategic Industry Growth
Leading companies in the albumin market are innovating products, such as recombinant albumin devoid of animal and human origins, to offer customers superior features. This animal- and human-origin-free recombinant albumin is manufactured using non-mammalian expression systems, like yeast, and contains no components derived from animals or humans. For example, in March 2023, Albumedix, a UK-based producer of recombinant human albumin (rHA), joined forces with Heartseed Inc., a Japan-based clinical-stage biotech company, to introduce Recombin. This vital excipient is intended for the manufacturing of Heartseed’s investigational cell therapy, HS-001, as its initial human clinical trial begins. This collaboration signifies a major advancement in the development of HS-001, which is set to revolutionize the treatment of diverse diseases. The incorporation of recombination in the production process ensures the cell therapy’s optimal performance and stability, reinforcing its potential for therapeutic triumph.
Albumin Market Key Players Shaping Industry Direction
Major companies operating in the albumin market are Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, Baxter International Inc., CSL Limited, Grifols SA, Mitsubishi Tanabe Pharma Corporation, Octapharma AG, Kedrion S.p.A., Biotest AG, Jiangxi Boya Bio-Pharmaceutical Co. Ltd., BPL (Bio Products Laboratory), Kamada Ltd., Proliant Biologicals, SeraCare Life Sciences Inc., HiMedia Laboratories, Albumedix Ltd., Medxbio Pte Ltd., Ventria Bioscience Inc., China Biologic Products Holdings Inc.
View The Full Albumin Market Report:
Albumin Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the albumin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
